Month: August 2024

SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by EisaiThe SEED-Eisai Research Collaboration leverages Eisai’s leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus tiered royalties upon Eisai’s exercise of their exclusive rights under the strategic research collaborationConcurrently, SEED has launched Series A-3 financing with a first close of $24 million from investors led by Eisai. A second close is targeted for Q4 2024The Series A-3 financing will advance clinical development of SEED’s internal lead program in cancer, expand its TPD platform and pipeline, and supplement prior investments in SEED from Eli Lilly and BeyondSpringKING OF PRUSSIA, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) — SEED Therapeutics...

Upon closing, Seres to receive $175M cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in Seres common stock, less approximately $20M in settlement of net obligations between the Parties; anticipated deal closing in the next 90 days Additional approximately $75M in cash payments are due to Seres in 2025, contingent upon Seres’ compliance with transition obligations, with the potential for additional future commercial milestone payments of up to $275M on the achievement of VOWST net sales targets Seres will fully retire its debt obligations upon closing Based on existing cash, deal economics and operating plans, Seres expects to fund operations into Q4 2025 Going forward, Seres to focus on improving patient outcomes in medically vulnerable populations with next generation...

         Total funding amount awarded to US transit agencies who named New Flyer as their partner of choice in 2024 grant applications has increased by 60% year-over-year. ST. CLOUD, Minn., Aug. 06, 2024 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leading independent bus and coach manufacturer and a leader in zero-emission electric mass mobility solutions, subsidiary New Flyer of America Inc. (New Flyer) today announced that it has been named the partner of choice in over $338 million of competitive grant awards through the Federal Transit Administration’s (FTA’s) 2024 Low- or No-Emission (Low-No) and Buses and Bus Facilities (BBF) programs. The award amount was spread across 14 transit agency partners. The FTA Low-No grant program was launched in 2015, with the first awards being dispersed in...

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) —  NexGold Mining Corp. (TSXV: NEXG) (OTCQX: NXGCF) (the “Company” or “NexGold”) and Wabigoon Lake Ojibway Nation (“WLON”) today announced a new Relationship Agreement (the “Agreement”) – a significant step towards Reconciliation and shared success in Canada’s mining sector. The Agreement compensates for historical exploration activities in the traditional territories of Wabigoon Lake Ojibway Nation and paves the way for improved First Nation participation in the future Goliath Gold Complex (“the Project”). Jeremy Wyeth, CEO of NexGold, stated, “NexGold couldn’t be prouder to be embarking on this renewed relationship. As a company, we’re honoured to operate on the traditional lands of the Wabigoon Lake Ojibway Nation, and we are committed to working together meaningfully and respectfully...

Tailored digital experiences score big with fans, advancing standards for engagement LOUISVILLE, Ky., Aug. 06, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (NASDAQ: CREX,), a leading provider of digital signage and media solutions, is proud to announce its strategic momentum and growth in the Sports and Entertainment (S&E) vertical. Creative Realities has been pivotal in transforming stadium and arena technology solutions and the way sports and entertainment venues engage with their audiences. Leveraging its advanced digital signage and CMS platform solutions, the company is providing venues with flexible, tailored packages that include IPTV, food and beverage (F&B) integration, and enhanced fan engagement experiences. These solutions not only maximize sponsorship revenue but also provide ongoing content strategy...

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company” or “Hemlo”) (CSE: HMLO) is pleased to announce that it has entered into binding share purchase agreements (“Purchase Agreements”) with shareholders of Rocky Shore Metals Ltd. (“Rocky Shore”) pursuant to which the Company has agreed to acquire all of the issued and outstanding common shares of Rocky Shore (“Rocky Shore Shares”) in exchange for the issuance of an aggregate of 49,999,704 common shares (“Hemlo Shares”) in the capital of the Company (the “Transaction”). Pursuant to the terms of the Transaction, each Rocky Shore Share will be exchanged for 2.832 Hemlo Shares. After closing of the transaction, Hemlo will have 100,724,624 shares outstanding. Transaction Highlights:Acquisition of 100% ownership of six (6) grass roots gold projects in a Tier...

MONTREAL, Aug. 06, 2024 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ).   OPEN TO: Investors, analysts and all interested partiesDATE: Wednesday, August 7, 2024TIME: 10:00 AM Eastern Daylight TimeLIVE WEBCAST: https://web.lumiagm.com/445332295   CALL: 1-866-518-4114   THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL THROUGH GLOBE NEWSWIRE. Please log on or dial in 15 minutes before the conference begins. If you are unable to attend at this time, you may access a web recording of the meeting at the following link: https://web.lumiagm.com/445332295. This recording will be available on Wednesday, August 7, 2024 as of 1:00 PM EDT until 11:59 PM EDT on Wednesday, August 14 2024. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION. ABOUT...

VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE:ASE | GSE:ASG) (“Asante” or the “Company”) is pleased to announce a progress update related to the planned sulphide treatment plant and rerouting of the Bibiani-Goaso Highway at the Bibiani Gold Mine (“Bibiani”). All dollar figures are in United States dollars unless otherwise indicated. Sulphide Plant Progress Update Installation of the sulphide plant is key to the Company’s plans to grow gold production at Bibiani to more than 250,000 ounces per year. Cumulative production of 1.2 million ounces of gold is anticipated over the next five years at lower all-in sustaining costs (“AISC”), as detailed in the 2024 Bibiani Technical Report (see May 1, 2024 press release). The plant is planned for completion in the first quarter of 2025, at a total...

Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected in fourth quarter of 2024 Progressing clinical studies in MDD, bipolar depression and Alzheimer’s disease agitation, providing opportunity for multiple value-creating catalysts over next 18 months Strong financial position with $371.6 million in cash, cash equivalents and marketable securities expected to support operations into 2026 WATERTOWN, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA) a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced financial results for the second quarter ended June 30, 2024, and provided a business update. “The first half of the year was marked by considerable progress across our robust clinical development...

Second quarter 2024 U.S. BRIUMVI net revenue of $72.6 million Raising full year 2024 U.S. BRIUMVI net revenue target to approximately $290 – $300 million Cash flow positive for second quarter 2024 Establishes $250 million credit facility to repay existing debt and to buy back up to $100 million of common stock under a share repurchase program Initiated phase 1 study in RMS patients for subcutaneous ublituximab and received FDA IND clearance to study azer-cel (allogeneic CD19 CAR-T) in patients with progressive MS Conference call to be held today, August 6, 2024, at 8:30 AM ET NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the second quarter of 2024, along with recent company developments and provided an update on...